Omniactive health technologies
Everstone Group has invested $35 million in a stake of Mumbai-based OmniActive Health Technologies Ltd.
Company lists
Drug development, genomics & research, medical devices, nutrition, startups and more: the companies building life sciences in New Jersey, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 794 life sciences companies in New Jersey, last 24 months: 98 M&A deals · 74 funding rounds · 27 Contracts · 5 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
Everstone Group has invested $35 million in a stake of Mumbai-based OmniActive Health Technologies Ltd.
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of ONS-5010/Lytenava, announced a $5.0 million registered direct…
ABN Amro Investment Solutions acquired a new stake in Insmed, Inc. (NASDAQ:INSM - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The…
Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent ('LoI') to evaluate a…
AustralianSuper Pty Ltd acquired a new stake in Insmed, Inc. (NASDAQ:INSM – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm…
Embecta announced it has completed its previously announced acquisition of Owen Mumford Holdings Limited, a privately held innovator and manufacturer of medical devices and drug delivery…
Swedish private equity firm EQT has emerged as the sole contender to acquire Sanjaya Mariwala-promoted OmniActive Health Technologies, after the only competing bid for the nutraceuticals…
Lisata Therapeutics, Inc. Announces Amendment and Waiver to Merger Agreement with Kuva Labs Inc.
Axtria, a global provider of AI‑first data analytics solutions for the life sciences industry, announced the acquisition of Conexus Solutions, a technology and managed services partner…
Catheter Precision, Inc. today announced it received shareholder approval on April 15 th of the definitive agreement to acquire Fly Flyte, Inc.
Origin, a London‑based HR technology startup, raised $30 million in a fresh funding round it calls an extended Series A+.
Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX ) today announced the closing of its previously announced underwritten public offering of 11,896,750 shares of its…
Origin has raised USD $30 million in a Series A+ funding round, bringing its total funding to more than USD $50 million within a year. The round was led by Notion Capital, which also…
Embecta Corp. (NASDAQ:EMBC) shares are up on Thursday after the company agreed to acquire Owen Mumford Holdings Limited. Deal Valued At Up To $200 Million Embecta values the acquisition…
Creatd Inc. has completed the sale of its remaining 80% equity stake in subsidiary Fly Flyte Inc. to Catheter Precision Inc., a company listed on the NYSE American exchange under the…
Lisata Therapeutics, Inc. entered into a definitive agreement to be acquired by Kuva Labs Inc.
LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence…
Avalon GloboCare Corp. (NASDAQ: ALBT) announced that it has entered into definitive agreements for the issuance and sale of 6,372,550 shares of its common stock … at a purchase price of…
Catheter Precision (NYSE:VTAK) announced today that it agreed to divest its atherectomy catheter technologies to an unnamed strategic acquirer.
The deal was initially announced in September 2022. Under the terms of the agreement, Catheter Precision became a wholly-owned subsidiary of Ra Medical with a focus on the cardiac…
Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the release of its sixth edition of the annual U.S. Incentive…
Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), today announced that it has mutually terminated the February 2021 Exclusive License and Collaboration Agreement with…
Lisata announced that it has entered into a binding term sheet to be acquired by Kuva Labs, Inc., whereby Kuva will commence a tender offer to purchase all of the outstanding shares of…
Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company ... today announced that it has entered into a binding term sheet to be…
Campbell & CO Investment Adviser LLC acquired a new stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) during the 3rd quarter, according to its most recent filing with the…
Cerity Partners LLC grew its holdings in ADMA Biologics by 1.8% in the 2nd quarter. Cerity Partners LLC now owns 48,572 shares of the biotechnology company’s stock valued at $884,000…
Amalgamated Bank grew its stake in ADMA Biologics by 0.8% in the 2nd quarter. Amalgamated Bank now owns 67,665 shares of the biotechnology company’s stock valued at $1,232,000 after…
New York State Teachers Retirement System boosted its holdings in shares of ADMA Biologics by 0.3% during the second quarter. New York State Teachers Retirement System now owns 222,461…
Quadrant Capital Group LLC grew its position in shares of ADMA Biologics by 3.9% in the second quarter. Quadrant Capital Group LLC now owns 16,660 shares of the biotechnology company’s…
Few life sciences companies in New Jersey publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 547 active companies.

Cell and gene therapy company creating treatments for genetic diseases
Rare diseasesUS$663.15m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of implantable device for treatment of chronic heart failure
Cardiac and vascular disordersUS$601.14m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable cardiac muscle stimulation devices and protein‑based therapeutic modulation.
CPC A61N1/3627, A61N1/025, A61N1/205Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of allogeneic cell therapies to treat multiple diseases
OncologyUS$290.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Placenta-derived cell and matrix therapies for regenerative, immuno, and anti‑aging applications
CPC A61K35/50, C12N5/0646, C12N5/0605Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapies for patients with cardiometabolic conditions
Cardiac and vascular disordersEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule drugs for the treatment of rare diseases
Rare diseasesUS$248.10m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule therapeutics for neurodegenerative and metabolic genetic disorders
CPC A61K31/4245, C07D271/06, C07D471/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Restoring mutated p53 function to treat cancer with precision oncology
OncologyUS$236.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of AI-powered data analytics and commercial solutions for life sciences
Healthcare itUS$198.74m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of non-invasive vagus nerve stimulation devices
NeurologyUS$161.39m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable and external nerve stimulation devices for therapeutic neuromodulation
CPC A61N1/36021, A61N1/0456, A61N1/36114Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Innovating therapies for unmet medical needs in hypertension, cardiorenal, and infectious diseases
Metabolic diseasesEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of laser and robotic systems for surgical purposes
Surgical instrumentsUS$126.09m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Surgical laser waveguide delivery and laparoscopic handpiece locking mechanisms
CPC A61B18/22, G02B6/02304, A61B34/76Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics to treat cancer
OncologyUS$130.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Innovating transformative treatments for ADHD, pain, and CNS disorders
NeurologyFocus: Extended-release oral dosage forms, especially gastro-retentive floating/raft drug delivery systems.
CPC A61K9/5021, A61K31/4458, A61K9/0065Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Biotechnology firm improving vascular access by reducing surgical stenosis
Cardiac and vascular disordersUS$123.28m across 12 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of minimally invasive products for musculoskeletal procedures
OrthopedicsFocus: Spinal and orthopedic implants with robotic assistance and integrated sensor technologies.
CPC A61F2/447, A61F2/4455, A61B34/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule based therapeutics for the treatment of cancer, metabolic, and autoimmune disorders
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of biologics for targeted immune regulation and restoration
ImmunotherapyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of protein therapeutics to treat nephrology and urological conditions
Metabolic diseasesUS$93.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Quantitative analytical methods for measuring antibiotics and calicheamicin in bone tissue
CPC G01N33/9446, G01N33/94Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule therapeutics for ophthalmic disorders
OphthalmologyUS$86.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of injectable non-opioid products for post-surgical pain control
NeurologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs to treat inflammation, HIV, liver disease and fibrosis
GastroenterologyUS$81.02m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Modular segmental solutions (3D printing) for orthopedic procedures
OrthopedicsUS$72.33m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Soft-tissue attachment technologies for orthopedic implants, including suture hole design and fixation methods.
CPC A61F2/0811, A61F2/30771, A61F2/3859Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the immuno-inflammatory conditions
DermatologyUS$62.89m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing glucan synthase inhibitors for the treatment of fungal infections.
Infectious diseasesUS$62.65m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K38/13, A61K31/4439, C07J71/0005Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule-based therapeutics for the treatment of CNS diseases
NeurologyUS$57.06m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced drug delivery films for epinephrine and prodrugs, oral and topical dosing
CPC A61K9/7007, A61K9/006, A61K31/137Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a specialty medical device company focusing on the development, manufacturing, and marketing of proprietary implantable ophthalmic devices designed to improve central vision for late-stage age-related macular degeneration (AMD) patients
OphthalmologyUS$55.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of antibodies for ophthalmic disorders
OphthalmologyUS$51.83m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Biodefense company delivering innovative medical countermeasures against infectious agents and public health concerns
Infectious diseasesUS$50.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of human protein therapeutics for multiple diseases
Infectious diseasesUS$45.41m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a topical formulation for the treatment of corneal wounds, ulcers, and scars
OphthalmologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Digital documentation and data management solutions for providers
MarketingtechUS$39.93m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of mobile-based healthcare diagnostics for diabetes prevention
Disease self managementUS$35.70m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Small molecule therapeutics targeting metabolic pathways to treat cancer
OncologyUS$31.92m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Invest 401k in physical gold, retirement planning, and financial advice
OncologyUS$30.36m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of antibodies against autoimmune disorders and metastatic tumors
NanotechnologyUS$26.93m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Nucleic-acid therapeutics for cancer/apoptosis and agricultural biotech for yield improvement
CPC C12N15/113, C07K14/4747, C12N9/0004Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of nucleic acid therapeutics for cancer and rare muscular disorders
OrthopedicsUS$26.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of drug delivery platform to treat gastrointestinal diseases
GastroenterologyUS$25.27m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing and marketing complex generic and specialty pharmaceutical products
DermatologyUS$23.44m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of regenerative products for musculoskeletal injury and disease
OrthopedicsUS$22.54m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Logistics software, big‑data analytics UI, data security, and citrate‑based bone graft implants
CPC G06Q10/083, A61F2/0811, G06F21/6245Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of hemoperfusion technology for removing toxins from the blood
Life sciences platforms and toolsFocus: Blood purification sorbents for removing toxins, cytokines, and potassium from plasma
CPC A61M1/3679, A61M1/3486, A61K31/745Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Functional food company developing and marketing omega-3 concentrates
Nutraceuticals techUS$21.08m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a drug delivery technology for ophthalmic diseases
OphthalmologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of mobile health self test platform
Disease self managementFocus: Optical and microfluidic biomedical assay platforms for blood and tissue diagnostics
CPC G01N33/54366, G01N33/497, G01N1/2813Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of anti-infectives to address antimicrobial resistance (AMR)
Infectious diseasesFocus: Computational drug ranking and design of antibacterial small‑molecule therapeutics.
CPC C07D401/14, A61P31/04, C07D277/42Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Innovating orthobiologics and wound care solutions for enhanced healing
OrthopedicsFocus: Autologous bone graft enhancement and marrow-derived cell/fluid separation technologies
CPC A61M1/02, B04B5/0414, A61M1/815Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapy to reverse coronary atherosclerosis
Cardiac and vascular disordersUS$17.79m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Biopharmaceutical company innovating plasma-derived therapeutics for immune deficiencies and infectious diseases
ImmunologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Biotechnology firm pioneering regenerative medicine, immune modulation, and reproductive health solutions
Women healthUS$17.19m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Peptide therapeutics and biomarker diagnostics for neurodegeneration, liver disease, and embryo viability
CPC A61K38/10, C07K7/06, A61K38/1709Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a cryotherapy device to cool the entire oral cavity
Ent disordersUS$15.90m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of specialty pharmaceutical company that focuses on responsible pain management
Pain managementEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of orthopedic-assited surgery devices
OrthopedicsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in New Jersey on RadarDiscover life sciences companies in New Jersey working in drug development, genomics, medical devices and research. Compare New Jersey life sciences companies by their scientific focus.
Businesses developing therapies, medicines and clinical programs.

Cell and gene therapy company creating treatments for genetic diseases
Rare diseases
Developer of allogeneic cell therapies to treat multiple diseases
Oncology
Developer of small molecule drugs for the treatment of rare diseases
Rare diseases
Restoring mutated p53 function to treat cancer with precision oncology
Oncology
Developer of non-invasive vagus nerve stimulation devices
NeurologyCompanies providing genomics, laboratory tools and research platforms.

Provider of reagents and instruments for life sciences research
GenomicsDeveloper of medical foods using nutrigenomics
Genomics
Developer of cancer diagnostic solutions for personalized treatment
Genomics
Developer of immunotherapies for the treatment of cancer and autoimmune diseases
Oncology
Provider of AI agents for healthcare data analysis and strategy
Life sciences techDevelopers of clinical devices, diagnostics and treatment technologies.

Provider of implantable device for treatment of chronic heart failure
Cardiac and vascular disorders
Developer of non-invasive vagus nerve stimulation devices
Neurology
Developer of laser and robotic systems for surgical purposes
Surgical instruments
Biotechnology firm improving vascular access by reducing surgical stenosis
Cardiac and vascular disorders
Developer of minimally invasive products for musculoskeletal procedures
OrthopedicsCompanies developing supplements, nutrition products and medical foods.

Functional food company developing and marketing omega-3 concentrates
Nutraceuticals tech
Manufacturer of dietary supplements to manage drinking side effects
Nutraceuticals tech
Manufacturing and marketing branded cellular nutrition supplements
Nutraceuticals tech
Provider of cellular diagnostic testing and personalized vitamins for optimized health
Nutraceuticals tech
Manufacturer of vitamin, protein and organic products
Nutraceuticals techRecently founded life sciences companies in New Jersey.

Developer of biologics for targeted immune regulation and restoration
Immunotherapy
Developer of anti-infectives to address antimicrobial resistance (AMR)
Infectious diseases
Developer of non-invasive brain temperature monitoring systems
PediatricsDeveloper of oral therapies for patients with inflammatory bowel diseases
Gastroenterology
Provider of AI agents for healthcare data analysis and strategy
Life sciences techLife sciences companies in New Jersey with current hiring activity.

Developer of small molecule drugs for the treatment of rare diseases
Rare diseases
Provider of AI-powered data analytics and commercial solutions for life sciences
Healthcare it
Innovating transformative treatments for ADHD, pain, and CNS disorders
Neurology
Developer of minimally invasive products for musculoskeletal procedures
Orthopedics
Developer of injectable non-opioid products for post-surgical pain control
NeurologyPublicly listed life sciences companies in New Jersey.

Developer of allogeneic cell therapies to treat multiple diseases
Oncology
Developer of small molecule drugs for the treatment of rare diseases
Rare diseases
Restoring mutated p53 function to treat cancer with precision oncology
Oncology
Developer of non-invasive vagus nerve stimulation devices
Neurology
Developer of minimally invasive products for musculoskeletal procedures
OrthopedicsThe most-installed Android apps published by life sciences companies headquartered in New Jersey — 437K installs between them. 7 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how New Jersey compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 794 life sciences companies in New Jersey among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesThe financials above are one chapter. The full life sciences landscape of New Jersey maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
115 life sciences companies in New Jersey have recorded equity funding, US$5.33bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
Rare diseasesCell and gene therapy company creating treatments for genetic diseases
Cardiac and vascular disordersProvider of implantable device for treatment of chronic heart failure
OncologyDeveloper of allogeneic cell therapies to treat multiple diseases
Developer of therapies for patients with cardiometabolic conditions
Rare diseasesDeveloper of small molecule drugs for the treatment of rare diseases
OncologyRestoring mutated p53 function to treat cancer with precision oncology
Healthcare itProvider of AI-powered data analytics and commercial solutions for life sciences
NeurologyDeveloper of non-invasive vagus nerve stimulation devices
Metabolic diseasesInnovating therapies for unmet medical needs in hypertension, cardiorenal, and infectious diseases
Founders
Details not available
Surgical instrumentsDeveloper of laser and robotic systems for surgical purposes
OncologyDeveloper of therapeutics to treat cancer
NeurologyInnovating transformative treatments for ADHD, pain, and CNS disorders
Cardiac and vascular disordersBiotechnology firm improving vascular access by reducing surgical stenosis
OrthopedicsDeveloper of minimally invasive products for musculoskeletal procedures
Founders
Details not available
ImmunotherapyDeveloper of biologics for targeted immune regulation and restoration
OncologyDeveloper of small molecule based therapeutics for the treatment of cancer, metabolic, and autoimmune disorders
US$663.15m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$601.14m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable cardiac muscle stimulation devices and protein‑based therapeutic modulation.
CPC A61N1/3627, A61N1/025, A61N1/205Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$290.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Placenta-derived cell and matrix therapies for regenerative, immuno, and anti‑aging applications
CPC A61K35/50, C12N5/0646, C12N5/0605Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$248.10m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule therapeutics for neurodegenerative and metabolic genetic disorders
CPC A61K31/4245, C07D271/06, C07D471/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$236.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$198.74m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$161.39m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable and external nerve stimulation devices for therapeutic neuromodulation
CPC A61N1/36021, A61N1/0456, A61N1/36114Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$126.09m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Surgical laser waveguide delivery and laparoscopic handpiece locking mechanisms
CPC A61B18/22, G02B6/02304, A61B34/76Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$130.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Extended-release oral dosage forms, especially gastro-retentive floating/raft drug delivery systems.
CPC A61K9/5021, A61K31/4458, A61K9/0065Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$123.28m across 12 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Spinal and orthopedic implants with robotic assistance and integrated sensor technologies.
CPC A61F2/447, A61F2/4455, A61B34/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in New Jersey. 338 of 547 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Cardiac and vascular disordersProvider of a portfolio of medical devices for interventional cardiology
Rare diseasesProvider of plasma-derived therapies for treating rare diseases
Founders
Details not available
NanotechnologyDeveloper of antibodies against autoimmune disorders and metastatic tumors
Life sciences techProvider of a platform for in silico drug discovery and consulting services
Ent disordersManufacturer of hearing-aid and related audio equipment
GenomicsProvider of reagents and instruments for life sciences research
Life sciences techDDi provides innovative technology products and solutions for organizations of various sizes.
Founders
Details not available
Life sciences techVeraqor is a technology consulting firm that provides IT consulting, cloud modernization, data management, and analytics.
Founders
Details not available
NanotechnologyProvider of specialty pharmaceutical products
Assistive techDeveloper of therapeutic solutions for treating age related diseases
Life sciences techDeveloper of a visual biology computing platform for drug discovery
OncologyDeveloper of small molecule drugs for oncology and autoimmune diseases
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$26.93m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Nucleic-acid therapeutics for cancer/apoptosis and agricultural biotech for yield improvement
CPC C12N15/113, C07K14/4747, C12N9/0004Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: AI-powered real-time document assistance and ML-driven mechanistic biological modeling tools.
CPC G16B5/00, G06F3/0484Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Adaptive video encoding and streaming technologies for multi‑resolution, 360° and bitrate optimization
CPC H04N21/2387, H04N19/593, G06F21/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Recombinant DNA cloning, protein engineering, electrophoresis devices, and immunoassay technologies.
CPC G01N33/54393, C07K16/34, C12N15/66Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in electrical & electronics
CPC H05K3/4623, A01M31/02, H05K3/4614Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$10.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in New Jersey with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
DermatologyDeveloping and marketing complex generic and specialty pharmaceutical products
Infectious diseasesDeveloper of human protein therapeutics for multiple diseases
Life sciences techProvider of AI-based research services
Nutraceuticals techProvider of cellular diagnostic testing and personalized vitamins for optimized health
OphthalmologyDeveloper of therapeutics for ophthalmic diseases
Developer of oral therapies for patients with inflammatory bowel diseases
Women healthBiotechnology firm pioneering regenerative medicine, immune modulation, and reproductive health solutions
NeurologyDrug for the treatment of L-Dopa Induced Dyskinesia in patients with Parkinson’s disease
Nutraceuticals techManufacturer of vitamin, protein and organic products
Drug deliveryManufacturer of infusion systems and accessories for subcutaneous drug administration
GenomicsProvider of carrier, cancer, prenatal screening and several genetic tests
Hospital equipmentNational provider of in-home medical equipment and support services
US$23.44m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$45.41m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.37m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$17.19m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Peptide therapeutics and biomarker diagnostics for neurodegeneration, liver disease, and embryo viability
CPC A61K38/10, C07K7/06, A61K38/1709Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Pharmaceutical formulations that mitigate sedation side effects in therapeutic compounds
CPC A61K31/485Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in New Jersey founded in the last four years, newest first.
Life sciences techProvider of AI agents for healthcare data analysis and strategy
HematologyDeveloper of epigenetic therapeutics targeting hemoglobinopathies like sickle cell disease
Manufacturer of digital dentistry solutions, including imaging, scanning, and CAD/CAM
Founders
Details not available
Life sciences techProvider of AI-driven platform for patient safety and workflow automation

ImmunotherapyDeveloper of biologics for targeted immune regulation and restoration
Developer of oral therapies for patients with inflammatory bowel diseases
Drug deliveryDeveloper of transdermal drug delivery systems
OncologyDeveloper of a diagnostic test for colorectal cancer diagnosis
Developer of taxane-based compounds for the treatment of cancer and other diseases
Nutraceuticals techProvider of nutritional supplements to improve health and well being
Founders
Details not available
Life sciences techProvider of tools for managing the logistics of recalled devices
Founders
Details not available
ImmunologyDeveloper of plant-based drugs for multiple diseases
Founders
Details not available
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
Rare diseasesDeveloper of small molecule drugs for the treatment of rare diseases
Infectious diseasesDeveloper of small molecule inhibitors for rare lung diseases
NeurologyDeveloper of injectable non-opioid products for post-surgical pain control
OrthopedicsDeveloper of minimally invasive products for musculoskeletal procedures
Founders
Details not available
Life sciences platforms and toolsDeveloper of drug delivery platform for skin and soft-tissue infections
NeurologyDeveloper of non-invasive vagus nerve stimulation devices
Life sciences platforms and toolsDeveloper of hemoperfusion technology for removing toxins from the blood
Life sciences techProvider of a platform for in silico drug discovery and consulting services
OphthalmologyDeveloper of antibodies for ophthalmic disorders
ImmunologyBiopharmaceutical company innovating plasma-derived therapeutics for immune deficiencies and infectious diseases
DiabetesManufacturer of insulin delivery solutions, including pen needles and insulin syringes
Founders
Details not available
Infectious diseasesDeveloping glucan synthase inhibitors for the treatment of fungal infections.
US$248.10m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule therapeutics for neurodegenerative and metabolic genetic disorders
CPC A61K31/4245, C07D271/06, C07D471/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Pulmonary anti-infective drug formulations and DPP1 inhibitor therapeutics
CPC A61K31/7036, A61K9/127, A61K31/553Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Spinal and orthopedic implants with robotic assistance and integrated sensor technologies.
CPC A61F2/447, A61F2/4455, A61B34/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.88m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Medical nitric oxide generation and delivery devices for therapeutic and diagnostic applications
CPC A61K33/00, A63B69/3691, A61N1/44Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$161.39m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable and external nerve stimulation devices for therapeutic neuromodulation
CPC A61N1/36021, A61N1/0456, A61N1/36114Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Blood purification sorbents for removing toxins, cytokines, and potassium from plasma
CPC A61M1/3679, A61M1/3486, A61K31/745Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: AI-powered real-time document assistance and ML-driven mechanistic biological modeling tools.
CPC G16B5/00, G06F3/0484Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$51.83m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$62.65m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K38/13, A61K31/4439, C07J71/0005Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in New Jersey. Open a company to see what it sells, who runs it and how far it has come.
100 life sciences companies in New Jersey work in life sciences tech. Shown: the best-documented.
Life sciences techProvider of AI-driven platform for patient safety and workflow automation

Life sciences techTechsol Corporation provides business solutions and technology services to CROs and pharmaceutical companies for enhancing clinical drug development

Healthcare itProvider of AI-powered data analytics and commercial solutions for life sciences
Life sciences techDeveloper of a visual biology computing platform for drug discovery
Life sciences techProduct launch and KOL management solutions for life sciences industry
Founders
Details not available
Life sciences techProvider of AI-based research services
Life sciences techProvider of regulatory affairs search tool for FDA and EMA data
Life sciences techProvider of AI agents for healthcare data analysis and strategy
MarketingtechDigital documentation and data management solutions for providers
Life sciences techProvider of a platform for in silico drug discovery and consulting services
Life sciences techDDi provides innovative technology products and solutions for organizations of various sizes.
Founders
Details not available
Life sciences techAI-enabled platform offering a range of functions for clinical research
Founders
Details not available

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$198.74m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$585k across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$39.93m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: AI-powered real-time document assistance and ML-driven mechanistic biological modeling tools.
CPC G16B5/00, G06F3/0484Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in electrical & electronics
CPC H05K3/4623, A01M31/02, H05K3/4614Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
67 life sciences companies in New Jersey work in life sciences platforms and tools. Shown: the best-documented.
GenomicsProvider of reagents and instruments for life sciences research
Life sciences platforms and toolsDeveloper of hemoperfusion technology for removing toxins from the blood
Life sciences platforms and toolsDeveloper of drug discovery platform
Founders
Details not available
Life sciences platforms and toolsDeveloper and markets p-Chip Micro transponders
Life sciences platforms and toolsDeveloper of drug delivery platform for skin and soft-tissue infections
Life sciences platforms and toolsOnline entertainment arena offering diverse games, community features, and digital empowerment
Life sciences platforms and toolsDeveloper of therapies for treating blood cancer, autoimmune diseases, and HIV
Life sciences platforms and toolsProvider of integrated services for drug discovery and clinical diagnostics
Founders
Details not available
GenomicsMolecular diagnostics and pathology services for early cancer diagnosis and treatment
Life sciences platforms and toolsRegenerative medicine expert specializing in bone, cartilage, and tissue regeneration
Biopharma outsourcingInnovating enhanced therapeutics using technology for specialty brand and generic products
GenomicsInVitro Cell Research is a privately funded company focused on regenerative and preventive personalized medicine.
Founders
Details not available
Focus: Recombinant DNA cloning, protein engineering, electrophoresis devices, and immunoassay technologies.
CPC G01N33/54393, C07K16/34, C12N15/66Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Blood purification sorbents for removing toxins, cytokines, and potassium from plasma
CPC A61M1/3679, A61M1/3486, A61K31/745Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$10.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Optical transponder biosensors and combinatorial antibody diagnostics for DNA assembly.
CPC A61B17/3468, G06K19/0704, G01N33/6845Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.88m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Medical nitric oxide generation and delivery devices for therapeutic and diagnostic applications
CPC A61K33/00, A63B69/3691, A61N1/44Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
66 life sciences companies in New Jersey work in oncology. Shown: the best-documented.
OncologyDeveloper of allogeneic cell therapies to treat multiple diseases
GenomicsDeveloper of cancer diagnostic solutions for personalized treatment
NanotechnologyDeveloper of antibodies against autoimmune disorders and metastatic tumors
OncologyRestoring mutated p53 function to treat cancer with precision oncology
OrthopedicsDeveloper of nucleic acid therapeutics for cancer and rare muscular disorders
NanotechnologyDeveloper of immunostimulatory nanoparticle vaccine for cancer and infectious diseases
OncologySmall molecule therapeutics targeting metabolic pathways to treat cancer
ImmunotherapyDeveloper of immunotherapies for the treatment of cancer
OncologyDeveloper of small molecule based therapeutics for the treatment of cancer, metabolic, and autoimmune disorders
DermatologyDeveloper of therapeutics for the immuno-inflammatory conditions
OncologyInvest 401k in physical gold, retirement planning, and financial advice
OncologyDeveloper of therapies for preventing metastasis and recurrence of cancers
US$290.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Placenta-derived cell and matrix therapies for regenerative, immuno, and anti‑aging applications
CPC A61K35/50, C12N5/0646, C12N5/0605Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$9.79m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular diagnostic microarrays for cancer classification, prognosis, and HPV-associated tumor detection.
CPC C12Q1/6886, C12Q1/6837, C12Q1/708Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$26.93m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Nucleic-acid therapeutics for cancer/apoptosis and agricultural biotech for yield improvement
CPC C12N15/113, C07K14/4747, C12N9/0004Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$236.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$26.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Non‑HLA‑restricted T‑cell vaccine platforms and cationic lipid delivery for cancer immunotherapy
CPC A61K39/39, A61K31/685, A61K31/231Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$31.92m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Engineered cytokine‑albumin fusion proteins for enhanced therapeutic biologics
CPC C07K16/244, C07K14/5434, A61K38/208Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$62.89m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$30.36m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.94m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
45 life sciences companies in New Jersey work in neurology. Shown: the best-documented.
Rare diseasesDeveloper of small molecule drugs for the treatment of rare diseases
NeurologyDeveloper of injectable non-opioid products for post-surgical pain control
NeurologyInnovating transformative treatments for ADHD, pain, and CNS disorders
NeurologyDeveloper of small molecule-based therapeutics for the treatment of CNS diseases
Founders
Details not available
NeurologyDeveloper of non-invasive vagus nerve stimulation devices
NeurologyDeveloper of a subcutaneous implant to monitor epilepsy
NeurologyDeveloper of the diagnostic test for neurodegenerative diseases
Life sciences platforms and toolsOnline entertainment arena offering diverse games, community features, and digital empowerment
NeurologyManufacturer of neurological drugs
NeurologyDeveloper of digital therapeutics for neuromuscular conditions
Diversified diagnosticsDeveloper of nanomedicine in-vitro diagnostics for high-consequence disease decision making
NeurologyDrug for the treatment of L-Dopa Induced Dyskinesia in patients with Parkinson’s disease
US$248.10m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule therapeutics for neurodegenerative and metabolic genetic disorders
CPC A61K31/4245, C07D271/06, C07D471/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Extended-release oral dosage forms, especially gastro-retentive floating/raft drug delivery systems.
CPC A61K9/5021, A61K31/4458, A61K9/0065Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$57.06m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced drug delivery films for epinephrine and prodrugs, oral and topical dosing
CPC A61K9/7007, A61K9/006, A61K31/137Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$161.39m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Implantable and external nerve stimulation devices for therapeutic neuromodulation
CPC A61N1/36021, A61N1/0456, A61N1/36114Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$554k across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$8.05m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$14.49m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Tethered enzyme biosensor platforms for enzymatic activity detection of clinical biomarkers
CPC G01N33/573, A61J1/05Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Pharmaceutical formulations that mitigate sedation side effects in therapeutic compounds
CPC A61K31/485Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
176 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.